Table 5.
Comparison between patients with awareness of antecedent symptoms and those without
| Parameter | Awareness of antecedent symptoms | P value | |||
|---|---|---|---|---|---|
| Absent | n | Present | n | ||
| Type of diabetes, type 1 (%)/type 2 (%) | 111 (44.2)/140 (55.8) | 251 | 77 (29.4)/185 (70.6) | 262 | < 0.0001 |
| Age at onset of severe hypoglycemia | 70.0 (56.0‒80.0) | 283 | 70.0 (57.0‒80.0) | 282 | 0.565 |
| Duration of diabetes (years) | 19.0 (11.0‒28.0) | 243 | 20.0 (11.0‒29.0) | 233 | 0.815 |
| BMI (kg/m2) | 21.2 (18.9‒24.1) | 266 | 22.1 (19.9‒24.7) | 244 | 0.004 |
| Glucose value at presentation (before treatment) | 30.0 (23.0‒40.0) | 233 | 34.5 (27.5‒43.0) | 228 | 0.001 |
| HbA1c at onset of severe hypoglycemia (%) | 7.2 (6.5‒8.3) | 255 | 7.2 (6.5‒8.1) | 239 | 0.615 |
| Serum creatinine at onset of severe hypoglycemia (mg/dL) | 0.9 (0.7‒1.4) | 261 | 0.9 (0.7‒1.4) | 264 | 0.365 |
| eGFR at onset of severe hypoglycemia (mL/min/1.73 m2) | 59.7 (36.2‒80.4) | 261 | 58.1 (35.3‒79.1) | 264 | 0.608 |
| Peripheral neuropathy, present | 141 (71.0%) | 200 | 99 (61.1%) | 162 | 0.047 |
| Autonomic neuropathy, present | 108 (59.7%) | 181 | 67 (47.9%) | 140 | 0.035 |
BMI body mass index, eGFR estimated glomerular filtration rate